[News] ESTRO 2023

January, 01, 2024 | Select Oncology Journal Articles

A single-arm, phase 2 study of short-course palliative radiotherapy (RT) for pancreatic cancer-related pain was presented by C Paola Tello Valverde (Amsterdam UMC, Amsterdam, Netherlands). Of 29 patients receiving palliative RT (24 Gy in three fractions, once a week), 24 (80·0%) had pain relief (primary endpoint; mean pain severity reduction using the Brief Pain Inventory from 5·9 to 2·9; p=0·017) during the first 11 weeks, and for 21 (70·0%) of those patients, the pain relief lasted until death or last follow-up.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy